Impact of Alzheimer's disease and rivastigmine treatment on activities of daily living over the course of mild to moderately severe disease
- 1 May 2002
- journal article
- clinical trial
- Published by Elsevier in Progress in Neuro-Psychopharmacology and Biological Psychiatry
- Vol. 26 (4) , 713-720
- https://doi.org/10.1016/s0278-5846(02)00212-9
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Behavioral and Psychological Symptoms of Dementia as a Risk Factor for Nursing Home PlacementInternational Psychogeriatrics, 2000
- Slowing on Quantitative Spectral EEG Is a Marker for Rate of Subsequent Cognitive and Functional Decline in Early Alzheimer DiseaseAlzheimer Disease & Associated Disorders, 1998
- Functional Disability in Alzheimer's DiseaseInternational Psychogeriatrics, 1997
- The Neglected Half of Alzheimer Disease: Cognitive and Functional Concomitants of Severe DementiaJournal of the American Geriatrics Society, 1994
- Predictors of the Placement of Cognitively Impaired Residents on Special Care UnitsThe Gerontologist, 1992
- Assessment of Functional Ability in Alzheimer DiseaseAlzheimer Disease & Associated Disorders, 1992
- Assessment of Functional Changes in Alzheimer's DiseaseNeuroepidemiology, 1990
- Clinical diagnosis of Alzheimer's diseaseNeurology, 1984
- The Global Deterioration Scale for assessment of primary degenerative dementiaAmerican Journal of Psychiatry, 1982
- “Mini-mental state”Journal of Psychiatric Research, 1975